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Abstract
Current treatments for tendon injuries often fail to fully restore joint biomechanics leading to the recurrence of symptoms,
and thus resulting in a significant health problem with a relevant social impact worldwide. Cell-based approaches involving
the use of stem cells might enable tailoring a successful tendon regeneration outcome. As growth factors (GFs) powerfully
regulate the cell biological response, their exogenous addition can further stimulate stem cells into the tenogenic lineage,
which might eventually depend on stem cells source. In the present study we investigate the tenogenic differentiation
potential of human- amniotic fluid stem cells (hAFSCs) and adipose-derived stem cells (hASCs) with several GFs associated
to tendon development and healing; namely, EGF, bFGF, PDGF-BB and TGF-b1. Stem cells response to biochemical stimuli
was studied by screening of tendon-related genes (collagen type I, III, decorin, tenascin C and scleraxis) and proteins found
in tendon extracellular matrix (ECM) (Collagen I, III, and Tenascin C). Despite the fact that GFs did not seem to influence the
synthesis of tendon ECM proteins, EGF and bFGF influenced the expression of tendon-related genes in hAFSCs, while EGF
and PDGF-BB stimulated the genetic expression in hASCs. Overall results on cellular alignment morphology,
immunolocalization and PCR analysis indicated that both stem cell source can be biochemically induced towards
tenogenic commitment, validating the potential of hASCs and hAFSCs for tendon regeneration strategies.
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Introduction
Tendons are highly prone to injury and their intrinsic
hypocellularity and hypovascularity makes their natural healing
extremely slow and inefficient when severely damaged. Surgical
repair with grafts is common but unsuccessful in a long term basis
as the biochemical and mechanical properties of healed tendon
tissue never match those of intact tendon, ultimately resulting in
the progression of degenerative diseases, such as osteoarthritis [1].
The regenerative mechanism underneath the unique organiza-
tion of collagen fibers and resident cell alignment in between the
fibers is still unknown. Thus, the limited ability of tendon to self-
repair and the limitation of treatment regimens have hastened the
motivation to develop stem cell-based strategies that explore the
natural endogenous system of tissue regeneration.
Amniotic fluid stem cells (AFSCs) have shown to be highly
proliferative, exhibiting high self-renewal capability and potential
to differentiate into several lineages [2]. In addition, human
AFSCs are easy to obtain, representing an almost unlimited stem
cell source with immunosuppressive properties [3].
Adipose tissue is also a promising source of stem cells as adipose-
derived stem cells (ASCs) have been explored for therapeutic
applications, and may represent a potential choice for tendon
repair and regeneration [4]. Tissue availability, easy and
minimally invasive access to adipose sources place these cells in
a unique position relative to other MSCs in the tissue engineering
and regenerative medicine (TERM) field. Moreover, human ASCs
(hASCs) isolation is a simple and relatively easy enzyme-based
methodology, and evidences suggest an immune-privileged
behavior [5].
We and others have demonstrated that under appropriate
inductive conditions human AFSCs [2,6,7] and hASCs can be
directed into several skeletal tissue-related lineages, such as bone
[2,6–8] and cartilage [2,6,8].
It is widely accepted that several different environmental factors
contribute to the overall control of stem cell activity [9]. Growth
factors (GFs) are potential agents to target specific tissue reactions
because of their regulatory roles in cellular functions, including
adhesion, proliferation, migration, matrix synthesis, and cell
differentiation [10]. For instance, fibroblast- (FGF), platelet
derived- (PDGF) and transforming- (TGF-b) growth factors are
markedly upregulated throughout tendon repair mechanisms [11].
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Since growth factors such as epidermal-(EGF), FGF, PDGF and
TGF-b have been described to play a role in tendon development
and tendon healing, they are to be investigated in this study.
EGF is a potent mitogen that participates in MSCs and
fibroblast proliferation [12,13], and is also involved in the initial
phase of tendon healing. Besides MSCs proliferation, EGF
treatment also preserves early progenitors within a MSC
population [12], and increases the paracrine activity of stem cells.
bFGF was recently described to maintain an undifferentiated
state of ligament stem cells (LSCs) [14]. Also, LSCs proliferate
faster with bFGF treatment [12,14]. FGF signaling is required for
the early stages of differentiation in a number of lineages and is
also an essential mediator of self-renewal in human stem cells [14].
Additionally, bFGF stimulates the production of collagenous and
non-collagenous ECM [15], thus evidencing a role in proliferation
and tendon commitment.
In vitro studies suggest that bFGF and PDGF not only stimulate
tendon fibroblast proliferation but promote changes in the
expression of matrix genes showing promise for improving tendon
healing [16]. PDGF also plays a role in the migration and
proliferation of the tenocytes, fibroblasts, and MSCs responsible
for tissue homeostasis. Furthermore, PDGF modulates the
synthesis of ECM [17] and supports the formation of a vascular
network, which sustains biofunctional and physiological integrity
[18] of the tissue. Its biological action highlights the PDGF
potential to treat and enhance the biologic response of injured
tendons and ligaments [19].
TGF-b has also been attracting attention in the tenogenic
regenerative field as TGF-b participates in all three phases of
tendon healing process: inflammation, proliferation and remodel-
ing [20]. Moreover, TGF-b has been described to be involved in
tendon formation [21], to induce tendon markers in mesenchymal
cells [22] and to stimulate upregulation of gene expression and
production of ECM in LSCs [14], playing a role in tendon cell
fate. The three isoforms of TGF-b (TGF-b1, TGF-b2, TGF-b3)
were shown to participate on collagen production and cell viability
[23]. In particular, TGF-b1 increased the production of collag-
enous and non-collagenous extracellular matrix protein in LSCs
[16].
Expanding and culturing cells while maintaining a tenogenic
phenotype would be useful in producing a more efficient tendon
bioengineered substitute. Although EGF, FGF, PDGF and TGF-b
were described to contribute to tendon and ligament development
and healing [1,21], the exact nature of tendon regeneration
remains unknown. Furthermore, the exogenous addition of GFs to
the cellular microenvironment could provide a trigger to assist the
differentiation of multipotent cells into a tenogenic lineage, and
establish a biochemical link between cells and native tissue, thus
participating in the process of restoring tendon functionality.
In this study we propose to assess the tenogenic potential of
human amniotic fluid-derived stem cells (hAFSCs) and human
adipose-derived stem cells (hASCs) in the presence of specific
biochemical culture conditions that might be used in cell-based
strategies for tendon repair.
We hypothesize that the exposure to the proper biochemical
cues, that is, GFs that participate in tendon formation and ECM
synthesis, would potentially stimulate tenogenic differentiation of
stem cells. Furthermore, the inclusion of these GFs in the culture
medium would enhance the expression of tendon- related markers
and the synthesis of tendon-like ECM. The successful tenogenic
differentiation of stem cells also outcomes for cell-laden scaffolding
strategies towards assisting and/or improving regeneration in locus.
An accelerated proliferation and remodeling process could
improve gliding and strength enhancement at the injury site and
simultaneously reduce the risk of fibrosis and tendon failure during
the repair/regenerative process.
Materials and Methods
Stem Cell Isolation and Expansion
Human amniotic fluid stem cells (hAFSCs) were obtained from
human amniotic fluid specimens collected during amniocentesis
procedures. The amniotic fluid was obtained under an IRB
protocol approved by Wake Forest School of Medicine. Back-up
human amniocentesis cultures, that would otherwise be discarded,
were harvested by trypsinization. Within the pool of hAFSCs the
c-Kit (CD117) positive population was immunoselected with
magnetic microspheres, whose protocol has been described in
detail elsewhere [2]. hAFSCs were assessed for several markers by
flow cytometry and showed to be negative for CD45, CD33 and
CD 133, and positive for CD73, CD90, CD105, CD29 and CD44
[2]. Then, hAFSCs were expanded and cryopreserved. The basic
amniotic fluid cell (BAFC) medium was composed by a-MEM
(Invitrogen) plus 15% embryonic screened FBS (ES-FBS, Fisher
Scientific), 1% glutamine (Sigma), 1% antibiotic/antimycotic (A/
A) solution (Gibco), 18% Chang B (Izasa/C101) and 2% Chang C
(Izasa/C108) at 37uC with 5% CO2 atmosphere.
Human ASCs were obtained from lipoaspirate samples of the
abdominal region, under protocols previously established with
Hospital da Prelada (Porto, Portugal) and with informed consent
of the patients. The content of the written informed consent and
related procedures were reviewed and approved by the Hospital
Ethics Committee.
Cells were isolated from tissue samples and cultured as
described before [22], and have been previously characterized
by RT-PCR for CD44, STRO-1, CD105 and CD90 markers
[22]. Briefly, the tissue was rinsed in phosphate-buffered saline
(PBS, Sigma-Aldrich) containing 10% of an antibiotic-antimycotic
solution (Gibco). The fat solution was immersed in a 0.05%
collagenase type II (Sigma/C6885) solution for 45 minutes at 37uC
under mild agitation. The digested tissue was centrifuged at 304 g
for 10 minutes at 4uC, after which the supernatant was eliminated.
Lysis buffer was used to dissolve the pellet followed by a
centrifugation at 304 g for 5 minutes. Cells were expanded in
basic medium composed of a-MEM (Invitrogen) supplemented
with 10% FBS (Alfagene), and 1% A/A solution (Alfagene).
The data obtained from amniocentesis back-up cultures and
from lipoaspirate samples was analyzed anonymously.
After reaching a sufficient cell number (approximately 380,000
cells),hAFSCs and hASCs were cultured in media conditioned
with different growth factors known to participate in tendon
healing mechanisms [1], as described in Table 1. The growth
factor’s concentration of 10 ng/mL was selected with basis on
previously published reports on tendon and ligament regeneration
strategies [14,24–26]. Thus, in this work we considered 10 ng/mL
studied as the minimum concentration of growth factor to likely
influence cellular differentiation.
The inclusion of ascorbic acid in the culture medium has been
associated with an increased MSCs proliferation and human
collagen synthesis, thus a positive and promising factor aiming at a
successful tenogenic medium.
Tenogenic differentiation was weekly evaluated up to 28 days
based on cell morphology and on the presence of Tenascin C,
Collagen I and Collagen III proteins, as well as on PCR analysis
for tendon-related markers (scleraxis, tenascin C, decorin, collagen
type I and collagen type III), as described in detail below.
Biochemically-Induced Tenogenesis of Stem Cells
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Morphological Analysis
Human AFSCs and hASCs were monitored daily and
photographs were obtained from live cells collected weekly using
a phase contrast microscope (Axiovert 40 CFL, Zeiss) (Figure S1
and S2). Multiple regions within each sample well were observed
and representative sections captured by a digital camera (Power-
Shot G11, Canon).
Immunolocalization of ECM Proteins: Collagen I, Collagen
III and Tenascin C
Samples from each culture condition were rinsed in PBS, fixed
in a 10% buffered formalin solution (43.05-k01009, INOPAT)
overnight and kept in PBS at 4uC until usage.
Collagen I (Rabbit polyclonal Anti-Collagen I, ab292, Abcam),
Collagen III (Monoclonal Anti-Collagen, Type III, C7805, Sigma-
Aldrich) and Tenascin C (Mouse monoclonal Anti-Tenascin C
antibody [BC-24], ab6393, Abcam) expression was assessed on
cells cultured onto tissue culture treated 6-well plates (Falcon).
After cell permeabilization with 0.025% Triton-X100 (Sigma/
X100)/PBS solution, the blocking step was performed using RTU
Normal Horse Serum (RTU Vectastain Kit, PK-7200, Vector).
Then, cells were incubated overnight with the primary antibodies
above mentioned, diluted in antibody diluent with background
reducing components from Dako (Dako) at 4uC.
The dilution ratio was optimized to 1:3000, 1:500, 1:3000 for
Tenascin C, Collagen I and Collagen III antibodies, respectively.
Afterwards, samples were rinsed in PBS, following inactivation
of endogenous peroxidase activity with hydrogen peroxide solution
(0.3% w/v, Panreac). The samples were incubated for 1 hour at
room temperature with the respective fluorescent secondary
antibody (rabbit anti-mouse Alexa Fluor 488/A11059, or donkey
anti-mouse Alexa Fluor 594/A21203, Invitrogen; dilution 1:200),
considering the host species of the primary antibodies.
After the incubation with secondary antibodies, samples were
rinsed in PBS and stained with 4,6-Diamidino-2-phenyindole,
dilactate (DAPI, 5 mg/ml, D9564, Sigma) for 10 minutes. Negative
controls assessed for immunofluorescence detection were incubat-
ed in Dako diluent in the absence of the primary antibody.
Finally, samples were incubated with a Phalloidin–Tetra-
methylrhodamine B isothiocyanate (Phalloidin) solution, which
was prepared accordingly to manufacturer’s instructions (P1951,
Sigma; dilution 1:200).
All samples were observed under a microscope (Imager Z1m,
Zeiss) and images were acquired using a digital camera (AxioCam
MRm5). The total growth surface area (9.6 cm2) of each well was
screened under the microscope. A minimum of 2 wells per sample,
condition and endpoint were analyzed. Also, a minimum of 2
samples per independent experiment (n = 3) were investigated for
protein detection by immunofluorescence.
RNA Isolation and Gene Expression Analysis
Total RNA was extracted using TRI ReagentH RNA Isolation
Reagent (T9424, Sigma) following the manufacture’s instruction.
RNA was quantified on a NanodropH ND-1000 spectrophotom-
eter (Thermo Scientific) and first-strand complementary DNA was
synthesized from 1 mg of RNA of each sample (qScriptTM cDNA
Synthesis Kit, Quanta Biosciences) in a 20 mL reaction using a
MastercyclerH ep realplex gradient S machine (Eppendorf).
Reverse transcription followed by the polymerase chain reaction
(RT-PCR) was the technique selected to analyze mRNA
expression derived from cells cultured in different media. RT-
PCR was performed to assess the gene expression of typical
markers for tenogenic differentiation, namely collagen type I,
collagen type III, tenascin C, decorin and scleraxis. The transcript
expression of target genes was analyzed and normalized to the
expression of endogenous housekeeping gene GAPDH (glyceral-
dehyde-3-phosphate dehydrogenase) (n = 3). The primers were
designed with Primer 3 software (Table 2) and synthesized by
MWG Biotech.
A 22DDCt method was used to evaluate the relative expression
level for each target gene. DCt values were obtained by the
difference between the Ct values of target genes and the GAPDH
gene. These values were then normalized by subtracting the DCt
value of the calibrator sample, their respective Ct value in basic
medium condition, to obtain DDCt values. Results are represented
as relative gene expression in comparison to calibrator sample that
is equal to 1.
Statistical Analysis
All quantitative results are expressed as the mean 6 standard
deviation.
Two-Way ANOVA followed by Bonferroni’s Multiple Com-
parison test were assessed to determine whether differences
between sample groups were significant. Differences were consid-
ered significant when the p value was ,0.05.
Table 1. Description of the culture medium composition to induce the tenogenic potential of hAFSCs and hASCs.
Medium Description
A) Basic medium: a-MEM, FBS (10%), A/A (1%)
B) AFSCs expansion medium (BAFC): a-MEM +15% ES-FBS, 1% glutamine, 1% antibiotic, 18% Chang B and 2% Chang C
C) hASCs: basic medium A+glutamine (2 mM) and ascorbic acid (0.2 mM)
D) Basic medium A+glutamine (2 mM)+ascorbic acid (0.2 mM)+EGF (10 ng/ml)
E) Basic medium A+glutamine (2 mM)+ascorbic acid (0.2 mM)+bFGF (10 ng/ml)
F) Basic medium A+glutamine (2 mM)+ascorbic acid (0.2 mM)+PDGF-BB (10 ng/ml)
G) Basic medium A+glutamine (2 mM)+ascorbic acid (0.2 mM)+TGF-b1 (10 ng/ml)
a-MEM: Minimum Essential Medium Eagle - Alpha Modification; FBS: fetal bovine serum; A/A: antibiotic/antimicotic solution; FBS-ES: fetal bovine serum embryonic screened;
EGF: endothelial growth factor (Peprotech/100-15); bFGF: basic-fibroblast growth factor (Peprotech/100-18B); PDGF-BB: platelet-derived growth factor (eBioscience/14-8501);
TGF-b1: transforming growth factor-b1 (eBioscience/14-8348).
doi:10.1371/journal.pone.0083734.t001
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Results and Discussion
Morphological Analysis and Cytoskeletal Arrangement of
Tenogenic Induced Cells
The typical morphology of tendon cells corresponds to a
spindle–like shape longitudinally oriented to tendon axis [21].
Since the morphologic features are important for achieving a
functional tissue, we investigated stem cell morphology when
cultured in the different conditioned media. To reveal the
cytoskeleton organization in response to the various GFs
supplemented media, cells were stained with phalloidin (Figure 1).
Differential Cytoskeleton Alignment in Distinct Stem Cell
Sources
Overall, both hAFSCs and hASCs developed an extensive
network of actin fibers by 14 days in culture. Nevertheless, cell
alignment was more evident in hAFSCs than in hASCs cultures.
By 21 days, both hAFSCs and hASCs evidenced an alignment
pattern in culture medium with PDGF-BB and TGF-b1. This
pattern was also observed in basic medium (A) and in medium
with bFGF in hAFSCs, but slightly faded in hASCs cultured in
basic medium (C). After 28 days in culture, hASCs alignment
could be detected in all culturing media, although in medium with
PDGF-BB the phalloidin stain was less intensive. For hAFSCs the
evidence of aligned distribution was only observed in medium
supplemented with EGF and PDGF-BB.
Interestingly, hAFSCs and hASCs evidenced an aligned
distribution in basic medium by 14 days and 28 days in culture,
respectively, indicating that these GFs are important but not
essential in achieving an aligned morphology of these cells.
Phalloidin selectively binds cell actin filaments and the actin
cytoskeleton has been suggested to have a relevant participation in
the alignment and organization of the collagenous ECM in
embryonic tendon [27]. Moreover, the longitudinal organization
of actin fibers within cell rows (observed in Figure S1 and Figure
S2) is a promising feature for sensing the tensile loads naturally
exerted by the muscle to the bone, transmitted to the tendon
tissue. Since actin fibers and cytoskeletal tension are often
associated, the synthesis of cytoplasmic mechanical fibers (resultant
from cytoskeletal rearrangement to meet the extracellular envi-
ronmental conditions) will ultimately be translated into biochem-
ical signals, which would trigger cell differentiation mechanisms.
Immunolocalization of ECM Proteins: Collagen I, Collagen
III and Tenascin C
The resident cells of mechanically functional tissues are often
responsible for the production and maintenance of the ECM,
including the collagen fibers. Collagen type I, Collagen type III
and Tenascin C are present and play a role in the ECM of native
tendon tissues. Thus, the immunolocalization of these proteins was
assessed as a tool to characterize the tendon-like matrix
synthesized by stem cells and stimulated into the tenogenic lineage.
Stem Cells Develop a Collagen I Rich Extracellular Matrix
in Different Supplement Media
During tendon development, collagen fibrillogenesis generates a
tendon-specific ECM that determines the functional intrinsic
mechanic properties of the tissue through cellular deposition of
parallel arrays of collagen fibrils.
The immunofluorescence analysis revealed that both hAFSCs
and hASCs developed a Collagen I-rich matrix in a timeline
sequence (Figure 1). The synthesis of collagen fibrils occurred first
as an intracellular step with assembly and secretion of procollagen
[28]. By 7 days in culture, Collagen I fluorescence signal was
concentrated around the nuclei, which likely corresponds to the
synthesized pro-collagen chains. Despite variations in the fluores-
cence signal, it occurred in both hAFSCs and hASCs and in all
conditioned media. Beyond 14 days, Collagen I was detected
outside hASCs in basic medium (C) and in media supplemented
with EGF, bFGF and PDGF-BB. Only in GFs supplemented
media the extracellular collagen synthesized by hAFSCs was
observed, and seemed to have an aligned fibrillar-like shape
(Figure 1). This process can be associated to the extracellular step
of collagen matrix production, where the pro-collagen is converted
into collagen and subsequent incorporation into stable cross-linked
collagen fibrils [28].
Extracellular collagen showed two distinct distribution patterns,
corresponding to a either aligned or randomly oriented matrix
network (Figure 1). The aligned pattern of Collagen I in hASCs
was widely observed in supplemented culture media with the
exception of medium with TGF-b1 after 14 days in culture. In
basic media (A and C) the collagen matrix was more randomly
dispersed. In hAFSCs the collagen distribution was more
randomly oriented after 21 days in culture, despite the saturation
of collagen outside the cells.
Overall, Collagen I was detected in both cell types and in all
conditioned media throughout the experimental timeline and the
collagenous matrix seemed to increase throughout the time in
culture.
Collagen III
Besides Collagen I, Collagen III has also an important role in
fibril formation. Collagen III copolymerizes with Collagen I, and
despite its low amount in the ECM, it provides tissue elasticity.
Table 2. Primers used for quantitative RT-PCR analysis.
Target gene Gene Abbreviation Forward Primer Reverse Primer Accession number
GAPDH GAPDH tgtaccaccaactgcttagc ggcatggactgtggtcatgag MN 002046.4
collagen, type I,
alpha 1
COL1A1 agccagcagatcgagaacat acacaggtctcaccggtttc NM_000088.3
collagen, type III,
alpha 1
COL3A1 gggaacatcctccttcaaca gcagggaacaacttgatggt NM_000090.3
tenascin C TNC gttaacgccctgactgtggt ccacaatggcagatccttct NM_002160.3
decorin DCN gccattgtcaacagcagaga cgagtggtccagtgttctga NM_001920.3
scleraxis homolog A SCXA tgccttgcagcctcttactt ctcccagtggagtgtggagt BK_000280.1
doi:10.1371/journal.pone.0083734.t002
Biochemically-Induced Tenogenesis of Stem Cells
PLOS ONE | www.plosone.org 4 December 2013 | Volume 8 | Issue 12 | e83734
Figure 1. Collagen I immunolocation in hAFSCs and hASCs cultured up to 28 days in different supplemented media. DAPI (blue)and
phalloidin-conjugate (red) stain cell nucleus and cytoskeleton, respectively. Collagen I is stained in green and represents the major tendon ECM
protein. Scale bar represents 100 mm. Magnification: 200 x.
doi:10.1371/journal.pone.0083734.g001
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Although the immunolocalization of Collagen III was assessed in
this study, in general its fluorescence signal was very mild (data was
not shown).
Tenascin C
Tenascin C is an ECM protein highly regulated by the tissue
microenvironment [29]. Although rarely present in most adult
tissues, Tenascin C is upregulated in embryonic and developing
tissues, or in tissues experiencing a fast rate of growth, and
influences cell adhesion and migration.
The fluorescent signal of Tenascin C was neglectable in
hAFSCs by 7 days in culture (Figure 2). After 2 weeks, the
expression increased in all culture conditions except in the
presence of bFGF. After 21 days, Tenascin C was not detected
in basic media (A and B) or in TGF-b1 supplemented medium.
Thus, medium supplemented with EGF, bFGF or PDGF-BB
seemed to influence Tenascin C production in hAFSCs for longer
periods of culture.
Similarly, Tenascin C was residually detected in hASCs after 7
days in the conditioned cultures. Nevertheless, the protein
detection tended to increase with the time in culture up to 21
days, being the strongest signal detected in EGF, PDGF-BB and
TGF-b1 culture media.
The expression of Tenascin C did not seem to be associated to
the alignment of cells per se. Another supportive data for this
statement relied on the fact that the Tenascin C protein network is
continuously synthesized, as observed by an increased fluorescence
signal in later time points, especially in hAFSCs. Despite the fact
that cells were proliferating, especially in longer culturing times,
the confluence of the cells on did not show to arrest proliferation
or detaching from the culture plate’s surface, as it is commonly
reported for other cell types.
Real Time RT-PCR
The immunolocalization procedures for ECM detection were
complemented with RT-PCR analysis of tendon-related markers
in order to enhance information and eventually establish a
timeline event for tenogenic differentiation on a molecular biology
and protein basis.
Decorin
Decorin is a proteoglycan that regulates tendon structure by
stabilizing and aligning collagen fibrils [30].
The decorin expression in hAFSCs was evident as early as 7
days in basic (A) and in EGF supplemented medium (Figure 3).
By 14 days, decorin values were similar to the GAPDH’s, and
increased again by 21 days in EGF and bFGF media. Only in
basic medium (A) hAFSCs expressed decorin after 4 weeks in
culture.
Conversely, decorin expression of hASCs only increased after
21 days in culture (Figure 3). The highest values were detected in
PDGF-BB and basic (C) media, followed by TGF-b1, bFGF and
EGF, respectively. Then, decorin expression decreased after 28
days for all studied media yet with increased values when
compared to the 14 day time point.
The influence of EGF medium can be explained by decorin
involvement in signal transduction through the EGF receptor.
Moreover, supplemented PDGF-BB is likely to participate in the
ECM synthesis by increasing decorin and collagen type I
expression in hASCs. PDGF-BB has been described to modulate
both fibroblast proliferation and ECM synthesis [18]. Although
TGF-b1 is known to interact with decorin, the functional
significance of this interaction is still unclear [31].
Collagen Type I and Type III
The major fibrillar component of tendon is type I collagen [21],
and the synthesis of collagen type I is the crucial step in
determination of the tensile strength of tendons [32].
In hASCs, collagen type I has an increased expression around
21 days in culture (Figure 3). The highest values were found for
cells cultured in PDGF-BB, basic (C) and TGF-b1 media,
respectively. Furthermore, collagen type I expression in hAFSCs
reached a peak by 21 days in EGF or bFGF media, although some
expression was detectable as early as 7 days in basic (A) and in
TGF-b1 conditioned media.
In both cell types, collagen type I expression correlated with the
gene expression of decorin. Furthermore, decorin seemed to be
upregulated due to growth factor supplementation, indicating a
catabolic state to collagenous matrix production. These results
confirm the mediator role of decorin in the process of collagen
fibrilogenesis and its involvement in the development of a tendon-
like fibril profile.
Besides collagen type I, collagen type III is essential for normal
fibrilogenesis and its regulation despite its smaller amounts in
tendon tissues.
In our study, the collagen type III expression showed high
values at the first time point in all media (Figure 3). The highest
levels were observed in basic medium (A), followed by culture
medium supplemented with PDGF-BB, TGF-b1, EGF and bFGF.
Collagen type III relative expression decreased by 14 days,
increasing again by 21 days for hAFSCs cultured in basic (A), EGF
and bFGF media. Although these values were maintained in basic
medium (A) at 28 days, they decreased in all other culture
conditions. Conversely, collagen type III expression of hASCs
maintained a basic level during the entire experiment, and was not
particularly influenced by the cell culturing conditions.
Tenascin C
The expression of tenascin C was maintained low in hAFSCs up
to 21 days in culture (Figure 3). Then, a pick in the expression level
was observed in media supplemented with EGF and bFGF.
Tenascin C relative expression in hASCs was high by 7 days in
culture, registering the highest values found in EGF supplemented
medium. The exception was made for cells cultured in basic
medium (B). After 2 weeks in culture, the expression decreased for
all but TGF-b1 culture medium, and increased to the highest
experimental values by 21 days in all conditioned media.
Overall, tenascin C was highly expressed after 21 days in
culture, being more homogeneously expressed in hASCs. On the
other hand, hAFSCs showed a peak of tenascin C only in EGF
and bFGF supplemented media.
Scleraxis
Scleraxis is a transcription factor expressed in the progenitors
and tendon tissue cells. In our study, scleraxis was upregulated by
7 days in basic (A) and EGF media and tended to increase in EGF
supplemented medium by 14 and 21 days in hAFSCs. A peak was
reached in bFGF medium by 21 days. Our results in hAFSCs are
justified by Reed and Johnson work on adipose and umbilical cord
blood stem cells [26]. These studies indicate that FGF signal is
necessary and sufficient for scleraxis expression of a tendon
progenitor cell population.
In hASCs, the scleraxis genetic expression was increased at day
7, especially in TGF-b1 medium, and overall culture media by day
21. These results are also supported by the literature since TGF-b
signaling is a potent inducer of scleraxis in cultured cells [3].
Biochemically-Induced Tenogenesis of Stem Cells
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Figure 2. Tenascin C immunolocation in hAFSCs and hASCs cultured up to 28 days in different supplemented media. DAPI (blue)and
phalloidin-conjugate (red) stain cell nucleus and cytoskeleton, respectively. Tenascin C is stained in green and represents a tendon ECM protein. Scale
bar represents 100 mm. Magnification: 200 x.
doi:10.1371/journal.pone.0083734.g002
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Human AFSCs and hASCs expressed all tendon-associated
genes studied, with increased expression values by 21 days in
culture.
The expression of the genetic markers had a dissimilar pattern
in hAFSCs and hASCs, indicating that these stem cell populations
respond differently to the different GFs. The expression of tendon-
related genes of hAFSCs seemed to be mainly influenced by EGF
and bFGF media while hASCs were more influenced by EGF and
PDGF-BB. Interesting is the fact that EGF participated in
stimulating the genetic expression of both hAFSCs and hASCs
but in a distinctive way; EGF influenced the expression of tenascin
C in hAFSCs and collagen type III expression in hASCs. Thus, the
genetic expression towards a tenogenic lineage commitment may
be influenced by stem cell origin, as cell origin may condition the
stem cell response to local biochemical environment, i.e. the media
composition.
General Discussion
Stem cell differentiation in general and tenogenic differentiation
in particular, are modulated by several biomolecules, including
Figure 3. Real time RT-PCR analysis. Expression of tenascin C (TNC), decorin (DCN), collagen type I (COL1A1), collagen type III (COL3A1) and
scleraxis (SCXA) genes in hAFSCs and hASCs cultured in different supplemented media. The x axis represents the culture time, namely 7, 14, 21 and 28
days. The relative gene expression is represented in the y axis. Horizontal lines represent differences statistically significant for p,0.05.
doi:10.1371/journal.pone.0083734.g003
Biochemically-Induced Tenogenesis of Stem Cells
PLOS ONE | www.plosone.org 8 December 2013 | Volume 8 | Issue 12 | e83734
growth factors presented in a highly defined and tunable micro-
environment. These biomolecules are expected to establish cell-to-
cell contact and interact with intracellular signaling molecules as a
responsive behavior to the extracellular milieu. The communica-
tion is likely to result in gene expression regulation, and ultimately
on the synthesis of proteins to promote cell mechanisms that
conduct to cell adjustments towards the external stimuli provided.
Since tendon associated markers are also found in other tissues
and cells, a combination of these markers may provide some
insight into the in vitro tenogenesis or tenogenic differentiation.
The presence of tendon-related ECM proteins namely Tenascin
C, Collagen I and Collagen III, described to have a key role in
healthy functional tendons, were detected in both stem cells.
The growth factors (GFs) were selected based on recent
publications, which associated these factors with tendon develop-
ment and healing mechanisms [17]. The main goal of the present
study was to understand how these GFs influence the tenogenic
differentiation of the two stem cell sources, so as to eventually help
defining an appropriate cell culture medium for inducing cells into
tenogenic lineage. Although the GFs studied clearly influenced the
stem cell response in terms of ECM production, none of these GFs
evidenced a distinctive action in the synthesis of tendon-related
proteins. Interestingly, the fluorescence signals for Tenascin C and
Collagen I protein are detected in culture conditions where the
genetic expression is low. We hypothesize that this effect may
occur due to the timeline translational determinants that take
place intracellularly from the upregulation of the interest gene to
the protein translation, and transport to the extracellular matrix
being produced. These results emphasize the complex dynamic of
the GFs in cell processes and environmental interactions that take
place in promoting cell differentiation in vitro.
Both hAFSCs and hASCs showed a longitudinal organization of
actin fibers within cell rows as well as alignment of collagen fibers,
suggesting that these are important morphological features to
investigate for a deeper understanding of the unique orientation of
the collagen fibrils in tendons.
Despite variations in the genetic expression levels of tendon-
associated markers, the GFs studied do not seem to be essential for
the biochemical stimulation of in vitro tenogenesis, as Tenascin C
and Collagen I were also observed in basic medium. It is likely that
stem cells studied may respond more promptly to mechanical
stimulation rather than to biochemical signals provided by the
culture medium.
Although pronounced conclusions were not achieved, the study
demonstrates that some growth factors have a greater effect in a
particular cell source than another, despite the fact that all growth
factors studied are associated to tendon healing mechanisms.
Since tendon is a mechanoresponsive tissue, appropriate
mechanical loads at physiological levels are usually beneficial to
tendons in terms of enhancing the mechanical properties of the
tendon [33], and achieving a healthy and functional tissue.
Tendon tissues require specific micro-environments according to
their function and correspondent anatomical regions. Therefore
we speculate that tenogenic differentiation of hASCs and hAFSCs
cultured in basal medium could be enhanced or accelerated in the
presence of an external mechanical stimulus.
The selection of the stem cell source seems to be relevant in
designing a tendon regeneration strategy. Despite the fact that
both hAFSCs and hASCs did follow a tenogenic pathway, the cell
responses to exogenous GFs stimulation were distinct, especially
the ones found at a molecular biology level. These results indicate
that the interactions occurring between these cells and the
biochemical milieu are complex and intrincated and may be
dependent on stem cell origin. These data point out the
importance of understanding the cellular and molecular events
induced by factors regulating stem cell proliferation and the
consequences on their cellular influence.
In summary: results on cellular alignment morphology, immu-
nolocalization and PCR analysis indicated that both stem cells can
be biochemically induced towards tenogenic features. The
stimulation into tenogenic lineage was demonstrated by the
elongated and aligned cell morphology, the presence of a Tenascin
C and Collagen I-rich ECM and the expression of gene markers
typically associated to tendon tissues. Despite variations found
between hAFSCs and hASCs responses to the GFs supplemented
to the culture medium, the results further validate the potential of
using adipose tissue and amniotic fluid as stem cell sources for
tendon tissue engineering.
Conclusion
The concept of stem cell inclusion in tendon-related strategies
increases the number of cells locally, stimulating tissue regener-
ation. Furthermore, the cellular commitment towards the teno-
genic lineage will simultaneously supply the local milieu with
growth factors and cytokines that could be important and lineage-
oriented for tendon regeneration.
Despite the relevance already described in tendon healing
mechanism, the growth factors evaluated in our study did not
emphasize a particular outcome on the tenogenic process of
hAFSCs and hASCs considering the synthesis of tenogenic ECM
proteins. Nevertheless, EGF and bFGF as well as EGF and PDGF-
BB do have a molecular influence on the tendon-related genetic
expression of hAFSCs and hASCs, respectively, although their role
in the process of tenogenic differentiation of stem cells is still
unveiled.
The fact that stem cells harvested and expanded from different
sources showed a distinct behavior to the GFs supplemented in the
culture medium may indicate that the origin of these cells may also
have an effect on the process of differentiation. Thus, the selection
of a source of stem cells should be considered as a potential
contribute for injury/defect-directed approaches in the regener-
ative medicine field.
These results also suggest that the tenogenic differentiation
follow complex and elaborated pathways that may depend on
multiple growth factors at precise chronological points and/or a
combination of multifactorial stimuli from the highly specific and
delicate tendon natural environment.
Supporting Information
Figure S1 Microscopic observation of hAFSCs cultured
up to 28 days in different supplemented media. Human
AFSCs photographs were obtained from live cells collected weekly
using a phase contrast microscope. Magnification: 100 x.
(TIF)
Figure S2 Microscopic observation of hASCs cultured
up to 28 days in different supplemented media. Human
ASCs photographs were obtained from live cells collected weekly
using a phase contrast microscope. Magnification: 100 x.
(TIF)
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